HNRNPA3P13

Across TCGA pan-cancer cohorts, HNRNPA3P13 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated HNRNPA3P13 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher HNRNPA3P13 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HNRNPA3P13 expression acts as an unfavorable survival marker, although some lineages such as KIRC and OV show a favorable association.

LUSC, STAD, and KIRC are the cancer types where HNRNPA3P13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Quartile	III,IV	0.110	1.000	.001	46	view →
STAD	DFS	Quartile	II,III,IV	0.362	0.578	.005	21	view →
KIRC	DFS	Tertile	III,IV	0.595	0.399	.010	21	view →
OV	DFS	Median	III,IV	0.198	0.114	.004	20	view →
LUAD	OS	Median	III,IV	0.494	0.809	.001	19	view →
CHOL	OS	Tertile	All	0.113	0.623	.040	18	view →
UVM	DFS	Tertile	III,IV	0.150	0.717	.005	17	view →
BLCA	DFS	Median	All	0.453	0.244	.003	16	view →
GBM	DFS	Median	All	0.169	0.299	.007	15	view →
DLBC	DFS	Median	All	0.388	0.921	.011	13	view →
THCA	DFS	Tertile	III,IV	0.953	0.570	.006	10	view →
PRAD	DFS	Quartile	All	0.972	0.914	.014	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

HNRNPA3P13–LUSC (DFS)

Open the LUSC breakdown →